These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8112475)
21. Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions. A study of untreated unsomniacs. Dujardin K; Guieu JD; Leconte-Lambert C; Leconte P; Borderies P; de La Giclais B Pharmacopsychiatry; 1998 Jan; 31(1):14-8. PubMed ID: 9524979 [TBL] [Abstract][Full Text] [Related]
22. Effect of zolpidem on sleep in insomniac patients. Monti JM Eur J Clin Pharmacol; 1989; 36(5):461-6. PubMed ID: 2666141 [TBL] [Abstract][Full Text] [Related]
23. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Roth T; Roehrs T; Vogel G Sleep; 1995 May; 18(4):246-51. PubMed ID: 7618022 [TBL] [Abstract][Full Text] [Related]
24. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428 [TBL] [Abstract][Full Text] [Related]
25. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia. Roth T; Steinberg F; Singh NN; Moline M Hum Psychopharmacol; 2014 Jan; 29(1):25-30. PubMed ID: 24424704 [TBL] [Abstract][Full Text] [Related]
26. A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects. Horoszok L; Baleeiro T; D'Aniello F; Gropper S; Santos B; Guglietta A; Roth T Hum Psychopharmacol; 2014 May; 29(3):266-73. PubMed ID: 24911577 [TBL] [Abstract][Full Text] [Related]
27. Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study. Cluydts R; Peeters K; de Bouyalsky I; Lavoisy J J Int Med Res; 1998; 26(1):13-24. PubMed ID: 9513073 [TBL] [Abstract][Full Text] [Related]
28. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem. Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092 [TBL] [Abstract][Full Text] [Related]
29. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468 [TBL] [Abstract][Full Text] [Related]
30. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. Perlis ML; McCall WV; Krystal AD; Walsh JK J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600 [TBL] [Abstract][Full Text] [Related]
31. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting. Hajak G; Bandelow B; Zulley J; Pittrow D Ann Clin Psychiatry; 2002 Mar; 14(1):1-7. PubMed ID: 12046635 [TBL] [Abstract][Full Text] [Related]
32. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia. Monti JM; Alvariño F; Monti D Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322 [TBL] [Abstract][Full Text] [Related]
33. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients. Frattola L; Maggioni M; Cesana B; Priore P Drugs Exp Clin Res; 1990; 16(7):371-6. PubMed ID: 2092963 [TBL] [Abstract][Full Text] [Related]
34. Zolpidem: clinical experience in psychiatric settings. Undén M Pol J Pharmacol; 1994; 46(5):483-5. PubMed ID: 7894539 [TBL] [Abstract][Full Text] [Related]
35. Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal. Monti JM; Monti D; Estévez F; Giusti M Int Clin Psychopharmacol; 1996 Dec; 11(4):255-63. PubMed ID: 9031992 [TBL] [Abstract][Full Text] [Related]
36. Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients. Schlich D; L'Heritier C; Coquelin JP; Attali P; Kryrein HJ J Int Med Res; 1991; 19(3):271-9. PubMed ID: 1670039 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Maroo N; Hazra A; Das T Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804 [TBL] [Abstract][Full Text] [Related]
38. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Hajak G; Cluydts R; Declerck A; Estivill SE; Middleton A; Sonka K; Unden M Int Clin Psychopharmacol; 2002 Jan; 17(1):9-17. PubMed ID: 11800507 [TBL] [Abstract][Full Text] [Related]
39. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. Nowell PD; Mazumdar S; Buysse DJ; Dew MA; Reynolds CF; Kupfer DJ JAMA; 1997 Dec 24-31; 278(24):2170-7. PubMed ID: 9417012 [TBL] [Abstract][Full Text] [Related]
40. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]